Novavax Capital Expenditure vs Net Cash Flow from Financing Analysis

NVAX Stock  USD 4.82  0.03  0.62%   
Trend analysis of Novavax balance sheet accounts such as Property Plant And Equipment Net of 515.5 M provides information on Novavax's total assets, liabilities, and equity, which is the actual value of Novavax to its prevalent stockholders. By breaking down trends over time using Novavax balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

About Novavax Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Novavax at a specified time, usually calculated after every quarter, six months, or one year. Novavax Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Novavax and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Novavax currently owns. An asset can also be divided into two categories, current and non-current.

Novavax Balance Sheet Chart

Novavax Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Novavax uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Novavax's Liabilities And Stockholders Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 4.3 B in 2024, despite the fact that Total Stockholder Equity is likely to grow to (681.1 M).

Total Assets

Total assets refers to the total amount of Novavax assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Novavax books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Novavax balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Novavax are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Accounts Payable

An accounting item on the balance sheet that represents Novavax obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Novavax are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Novavax's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novavax current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.At this time, Novavax's Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 442.5 M in 2024, despite the fact that Tax Provision is likely to grow to (1.8 M).

Novavax fundamental ratios Correlations

0.780.94-0.560.87-0.87-0.910.930.940.90.940.940.930.80.940.960.860.990.880.78-0.460.71-0.410.67-0.370.33
0.780.9-0.890.91-0.66-0.90.930.720.880.750.680.840.550.850.90.910.70.550.66-0.350.53-0.320.34-0.260.02
0.940.9-0.750.86-0.88-0.920.960.940.870.930.920.880.830.890.980.860.920.760.67-0.40.68-0.410.55-0.360.21
-0.56-0.89-0.75-0.740.40.79-0.72-0.53-0.71-0.63-0.45-0.69-0.4-0.69-0.76-0.75-0.48-0.4-0.620.35-0.560.21-0.060.15-0.19
0.870.910.86-0.74-0.62-0.960.910.70.990.770.690.970.460.960.921.00.780.740.87-0.430.56-0.360.46-0.30.14
-0.87-0.66-0.880.4-0.620.67-0.82-0.94-0.65-0.87-0.94-0.67-0.9-0.68-0.8-0.61-0.91-0.74-0.380.22-0.450.47-0.60.46-0.03
-0.91-0.9-0.920.79-0.960.67-0.93-0.8-0.97-0.86-0.77-0.98-0.6-0.99-0.97-0.96-0.85-0.77-0.890.5-0.720.34-0.480.28-0.33
0.930.930.96-0.720.91-0.82-0.930.890.910.830.880.90.740.920.960.910.890.680.7-0.410.67-0.40.65-0.360.17
0.940.720.94-0.530.7-0.94-0.80.890.730.920.990.770.950.80.90.690.970.760.57-0.40.73-0.410.71-0.390.34
0.90.880.87-0.710.99-0.65-0.970.910.730.810.720.990.490.980.930.990.820.790.89-0.440.59-0.350.47-0.290.19
0.940.750.93-0.630.77-0.87-0.860.830.920.810.90.850.820.860.940.770.940.90.71-0.430.66-0.440.45-0.410.35
0.940.680.92-0.450.69-0.94-0.770.880.990.720.90.760.940.790.880.670.980.770.55-0.410.7-0.40.74-0.380.32
0.930.840.88-0.690.97-0.67-0.980.90.770.990.850.760.550.990.950.970.860.840.92-0.480.65-0.390.5-0.340.29
0.80.550.83-0.40.46-0.9-0.60.740.950.490.820.940.550.590.750.450.870.610.33-0.320.68-0.360.67-0.360.34
0.940.850.89-0.690.96-0.68-0.990.920.80.980.860.790.990.590.960.960.870.820.91-0.50.7-0.340.54-0.280.33
0.960.90.98-0.760.92-0.8-0.970.960.90.930.940.880.950.750.960.920.920.820.81-0.470.73-0.390.54-0.340.32
0.860.910.86-0.751.0-0.61-0.960.910.690.990.770.670.970.450.960.920.770.730.87-0.420.55-0.360.43-0.290.13
0.990.70.92-0.480.78-0.91-0.850.890.970.820.940.980.860.870.870.920.770.870.7-0.450.71-0.410.72-0.380.36
0.880.550.76-0.40.74-0.74-0.770.680.760.790.90.770.840.610.820.820.730.870.77-0.380.49-0.460.41-0.430.31
0.780.660.67-0.620.87-0.38-0.890.70.570.890.710.550.920.330.910.810.870.70.77-0.550.7-0.240.39-0.180.52
-0.46-0.35-0.40.35-0.430.220.5-0.41-0.4-0.44-0.43-0.41-0.48-0.32-0.5-0.47-0.42-0.45-0.38-0.55-0.590.11-0.320.08-0.53
0.710.530.68-0.560.56-0.45-0.720.670.730.590.660.70.650.680.70.730.550.710.490.7-0.59-0.120.65-0.10.82
-0.41-0.32-0.410.21-0.360.470.34-0.4-0.41-0.35-0.44-0.4-0.39-0.36-0.34-0.39-0.36-0.41-0.46-0.240.11-0.12-0.340.990.09
0.670.340.55-0.060.46-0.6-0.480.650.710.470.450.740.50.670.540.540.430.720.410.39-0.320.65-0.34-0.340.37
-0.37-0.26-0.360.15-0.30.460.28-0.36-0.39-0.29-0.41-0.38-0.34-0.36-0.28-0.34-0.29-0.38-0.43-0.180.08-0.10.99-0.340.09
0.330.020.21-0.190.14-0.03-0.330.170.340.190.350.320.290.340.330.320.130.360.310.52-0.530.820.090.370.09
Click cells to compare fundamentals

Novavax Account Relationship Matchups

Novavax fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets173.0M1.6B2.6B2.3B1.9B1.9B
Other Current Liab19.9M(327.6M)709.8M1.5B1.2B1.3B
Total Current Liabilities25.8M322.0M2.4B2.5B1.6B1.7B
Total Stockholder Equity(186.0M)627.2M(351.7M)(634.1M)(716.9M)(681.1M)
Property Plant And Equipment Net11.4M180.0M228.7M400.5M491.0M515.5M
Net Debt243.1M(231.4M)(1.1B)(787.1M)(298.3M)(283.4M)
Retained Earnings(1.4B)(1.9B)(3.6B)(4.3B)(4.8B)(4.6B)
Accounts Payable2.9M54.3M127.1M216.5M132.6M139.2M
Cash78.8M553.4M1.5B1.3B578.9M607.9M
Non Current Assets Total75.7M334.3M421.6M555.3M711.5M747.0M
Non Currrent Assets Other7.5M13.2M56.7M28.5M30.3M31.8M
Cash And Short Term Investments78.8M711.0M1.5B1.3B578.9M607.9M
Common Stock Shares Outstanding24.1M57.6M74.4M78.2M100.8M105.8M
Liabilities And Stockholders Equity173.0M1.6B2.6B2.3B1.9B1.9B
Other Current Assets93.9M441.8M2.1B1.7B226.0M191.7M
Other Stockholder Equity1.3B2.5B3.3B3.6B4.1B4.3B
Total Liab359.0M955.3M2.9B2.9B2.6B2.7B
Property Plant And Equipment Gross11.4M180.0M258.6M447.8M566.0M594.3M
Total Current Assets97.2M1.2B2.2B1.7B1.1B1.2B
Accumulated Other Comprehensive Income(12.5M)7.0M(1.4M)(6.4M)2.7M2.9M
Net Receivables7.5M262.0M455.0M82.4M297.2M312.1M
Non Current Liabilities Total333.2M633.2M538.1M432.8M937.1M984.0M
Intangible Assets6.5M5.6M5.7M4.8M4.3M4.1M
Short Long Term Debt Total321.9M322.0M454.0M549.8M280.6M294.7M
Common Stock Total Equity3.8M324K714K764K878.6K1.3M
Short Term Debt1.3M322.0M130.5M352.1M28.1M43.9M
Common Stock324K714K764K868K1.4M1.3M
Long Term Debt320.6M322.0M323.5M166.5M168.0M114.6M
Inventory(83.0M)(166.7M)(2.0B)36.7M41.7M43.8M
Property Plant Equipment11.4M180.0M228.7M400.5M460.6M483.6M
Other Liab2.6M3.4M175.5M185.0M212.8M223.4M
Current Deferred Revenue1.7M273.2M1.4B370.1M241.3M140.2M
Other Assets1.1M5.4M16.6M28.5M32.7M34.4M
Good Will51.2M135.4M131.5M126.3M127.5M133.8M
Net Tangible Assets(242.8M)486.1M(487.9M)(760.4M)(684.4M)(650.1M)
Retained Earnings Total Equity(1.3B)(1.4B)(1.9B)(3.6B)(3.3B)(3.1B)
Long Term Debt Total319.2M320.6M322.0M323.5M372.0M234.9M
Capital Surpluse1.1B1.3B2.5B3.4B3.9B4.0B

Novavax Investors Sentiment

The influence of Novavax's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Novavax. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Novavax's public news can be used to forecast risks associated with an investment in Novavax. The trend in average sentiment can be used to explain how an investor holding Novavax can time the market purely based on public headlines and social activities around Novavax. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Novavax's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Novavax's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Novavax's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Novavax.

Novavax Implied Volatility

    
  139.55  
Novavax's implied volatility exposes the market's sentiment of Novavax stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Novavax's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Novavax stock will not fluctuate a lot when Novavax's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novavax in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novavax's short interest history, or implied volatility extrapolated from Novavax options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Novavax offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Novavax's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novavax Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novavax Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.
Note that the Novavax information on this page should be used as a complementary analysis to other Novavax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Novavax Stock analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
CEOs Directory
Screen CEOs from public companies around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Is Novavax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novavax. If investors know Novavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novavax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.41)
Revenue Per Share
9.762
Quarterly Revenue Growth
(0.18)
Return On Assets
(0.17)
Return On Equity
(8.98)
The market value of Novavax is measured differently than its book value, which is the value of Novavax that is recorded on the company's balance sheet. Investors also form their own opinion of Novavax's value that differs from its market value or its book value, called intrinsic value, which is Novavax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novavax's market value can be influenced by many factors that don't directly affect Novavax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novavax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novavax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novavax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.